Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt repayments
Ratios

Abvc Biopharma (ABVC) Short-Term Debt repayments (2019 - 2025)

Historic Short-Term Debt repayments for Abvc Biopharma (ABVC) over the last 7 years, with Q3 2025 value amounting to $31406.0.

  • Abvc Biopharma's Short-Term Debt repayments fell 5095.65% to $31406.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $474199.0, marking a year-over-year increase of 64050.78%. This contributed to the annual value of $599552.0 for FY2024, which is 4004.48% down from last year.
  • Abvc Biopharma's Short-Term Debt repayments amounted to $31406.0 in Q3 2025, which was down 5095.65% from $29625.0 recorded in Q2 2025.
  • Over the past 5 years, Abvc Biopharma's Short-Term Debt repayments peaked at $1.0 million during Q1 2023, and registered a low of $4629.0 during Q1 2021.
  • Moreover, its 4-year median value for Short-Term Debt repayments was $31406.0 (2025), whereas its average is $220409.3.
  • Per our database at Business Quant, Abvc Biopharma's Short-Term Debt repayments plummeted by 9354.29% in 2021 and then plummeted by 5095.65% in 2025.
  • Quarter analysis of 4 years shows Abvc Biopharma's Short-Term Debt repayments stood at $4629.0 in 2021, then skyrocketed by 21502.94% to $1.0 million in 2023, then plummeted by 61.61% to $383918.0 in 2024, then tumbled by 91.82% to $31406.0 in 2025.
  • Its Short-Term Debt repayments stands at $31406.0 for Q3 2025, versus $29625.0 for Q2 2025 and $29250.0 for Q1 2025.